Enhancement of adoptive T cell transfer with single low dose pretreatment of doxorubicin or paclitaxel in mice

Ex vivo expansion of CD8(+) T-cells has been a hindrance for the success of adoptive T cell transfer in clinic. Currently, preconditioning with chemotherapy is used to modulate the patient immunity before ACT, however, the tumor microenvironment beneficial for transferring T cells may also be damage...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Fei-Ting, Chen, Tzu-Chun, Chuang, Hui-Yen, Chang, Ya-Fang, Hwang, Jeng-Jong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper: Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792547/
https://www.ncbi.nlm.nih.gov/pubmed/26683520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792547/
https://www.ncbi.nlm.nih.gov/pubmed/26683520

Ejemplares similares